By Type-
Lateral Flow Assay Market By Application-
Lateral Flow Assay Market By Technique
Lateral Flow Assay Market By Sample type
Lateral Flow Assay Market By End Users
Lateral Flow Assay Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Lateral Flow Assays Market Snapshot
Chapter 4. Global Lateral Flow Assays Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Type:
5.2.1. Kits & Reagents
5.2.2. Lateral Flow Readers
Chapter 6. Market Segmentation 2: By Technique Estimates & Trend Analysis
6.1. By Technique & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Technique:
6.2.1. Sandwich Assays
6.2.2. Competitive Assays
6.2.3. Multiplex Detection Assays
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Application:
7.2.1. Clinical Testing
7.2.2. Veterinary Diagnostics
7.2.3. Food Safety & Environmental Testing
7.2.4. Drug Development & Quality Testing
Chapter 8. Market Segmentation 4: By Sample Type Estimates & Trend Analysis
8.1. By Sample Type & Market Share, 2020 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Sample Type:
8.2.1. Blood Samples
8.2.2. Urine Samples
8.2.3. Saliva Samples
8.2.4. Other Samples
Chapter 9. Market Segmentation 5: By End User Estimates & Trend Analysis
9.1. By End User & Market Share, 2020 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End User:
9.2.1. Hospitals & Clinics
9.2.2. Diagnostics Laboratories
9.2.3. Home Care Settings
9.2.4. Pharmaceuticals & Biotechnology Companies
9.2.5. Other End User
Chapter 10. Lateral Flow Assays Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Lateral Flow Assays Market revenue (US$ Million) estimates and forecasts By Type, 2019-2031
10.1.2. North America Lateral Flow Assays Market revenue (US$ Million) estimates and forecasts By Technique, 2019-2031
10.1.3. North America Lateral Flow Assays Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031
10.1.4. North America Lateral Flow Assays Market revenue (US$ Million) estimates and forecasts By Sample Type, 2019-2031
10.1.5. North America Lateral Flow Assays Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031
10.1.6. North America Lateral Flow Assays Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
10.2. Europe
10.2.1. Europe Lateral Flow Assays Market revenue (US$ Million) By Type, 2019-2031
10.2.2. Europe Lateral Flow Assays Market revenue (US$ Million) By Technique, 2019-2031
10.2.3. Europe Lateral Flow Assays Market revenue (US$ Million) By Application, 2019-2031
10.2.4. Europe Lateral Flow Assays Market revenue (US$ Million) By Sample Type, 2019-2031
10.2.5. Europe Lateral Flow Assays Market revenue (US$ Million) By End User, 2019-2031
10.2.6. Europe Lateral Flow Assays Market revenue (US$ Million) by country, 2019-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Lateral Flow Assays Market revenue (US$ Million) By Type, 2019-2031
10.3.2. Asia Pacific Lateral Flow Assays Market revenue (US$ Million) By Technique, 2019-2031
10.3.3. Asia Pacific Lateral Flow Assays Market revenue (US$ Million) By Application, 2019-2031
10.3.4. Asia Pacific Lateral Flow Assays Market revenue (US$ Million) By Sample Type, 2019-2031
10.3.5. Asia Pacific Lateral Flow Assays Market revenue (US$ Million) By End User, 2019-2031
10.3.6. Asia Pacific Lateral Flow Assays Market revenue (US$ Million) by country, 2019-2031
10.4. Latin America
10.4.1. Latin America Lateral Flow Assays Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
10.4.2. Latin America Lateral Flow Assays Market revenue (US$ Million) By Technique, (US$ Million) 2019-2031
10.4.3. Latin America Lateral Flow Assays Market revenue (US$ Million) By Application, (US$ Million) 2019-2031
10.4.4. Latin America Lateral Flow Assays Market revenue (US$ Million) By Sample Type, (US$ Million) 2019-2031
10.4.5. Latin America Lateral Flow Assays Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
10.4.6. Latin America Lateral Flow Assays Market revenue (US$ Million) by country, 2019-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Lateral Flow Assays Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
10.5.2. Middle East & Africa Lateral Flow Assays Market revenue (US$ Million) By Technique, (US$ Million) 2019-2031
10.5.3. Middle East & Africa Lateral Flow Assays Market revenue (US$ Million) By Application, (US$ Million) 2019-2031
10.5.4. Middle East & Africa Lateral Flow Assays Market revenue (US$ Million) By Sample Type, (US$ Million) 2019-2031
10.5.5. Middle East & Africa Lateral Flow Assays Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
10.5.6. Middle East & Africa Lateral Flow Assays Market revenue (US$ Million) by country, 2019-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Abbott Laboratories (US),
11.2.2. Quidel Corporation (US),
11.2.3. F. Hoffman-La Roche AG (Switzerland),
11.2.4. Danaher Corporation (US),
11.2.5. Siemens AG (Germany),
11.2.6. BD (US),
11.2.7. bioMérieux SA (France),
11.2.8. Thermo Fisher Scientific, Inc. (US),
11.2.9. PerkinElmer Inc. (US),
11.2.10. Hologic Inc. (US),
11.2.11. QIAGEN N.V. (Netherlands),
11.2.12. Merck KGaA (Germany).
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.